BNTX (BioNTech SE) Other Operating Expense : $-20 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioNTech SE Other Operating Expense?

BioNTech SE's Other Operating Expense for the three months ended in Dec. 2024 was $-696 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-20 Mil.

BioNTech SE's quarterly Other Operating Expense increased from Jun. 2024 ($287 Mil) to Sep. 2024 ($394 Mil) but then declined from Sep. 2024 ($394 Mil) to Dec. 2024 ($-696 Mil).

BioNTech SE's annual Other Operating Expense increased from Dec. 2022 ($-70 Mil) to Dec. 2023 ($-28 Mil) but then declined from Dec. 2023 ($-28 Mil) to Dec. 2024 ($-50 Mil).

BioNTech SE Other Operating Expense Historical Data

The historical data trend for BioNTech SE's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Other Operating Expense Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

-301.83

-156.27

-70.34

-28.14

-49.95

BioNTech SE Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															-174.70	-4.78	287.08	393.56	-695.92

BioNTech SE Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20 Mil.

BioNTech SE Other Operating Expense Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (NAS:BNTX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

BNTX:Mexico 22UAd:UK 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.